Pharmacologic treatment of portal hypertension: Past, present, and future

被引：25

作者：

Boyer, TD ^{[1
]}

机构：

[1] Univ Arizona, Hlth Sci Ctr, Liver Res Inst, Tucson, AZ 85724 USA

来源：

HEPATOLOGY | 2001年 / 34卷 / 04期

关键词：

D O I：

10.1053/jhep.2001.27545

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：834 / 839

页数：6

共 45 条

[1] New treatments for hepatorenal syndrome [J].

Arroyo, V .

LIVER TRANSPLANTATION, 2000, 6 (03) :287-289

[2] CIRCULATING LEVELS OF ENDOTHELIN IN CIRRHOSIS [J].

ASBERT, M ;

GINES, A ;

GINES, P ;

JIMENEZ, W ;

CLARIA, J ;

SALO, J ;

ARROYO, V ;

RIVERA, F ;

RODES, J .

GASTROENTEROLOGY, 1993, 104 (05) :1485-1491

[3] Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis [J].

Bañares, R ;

Moitinho, E ;

Piqueras, B ;

Casado, M ;

García-Pagán, JC ;

de Diego, A ;

Bosch, J .

HEPATOLOGY, 1999, 30 (01) :79-83

[4] DRUG-THERAPY OF PORTAL-HYPERTENSION DUE TO CIRRHOSIS [J].

BENHAMOU, JP ;

LEBREC, D .

SEMINARS IN LIVER DISEASE, 1982, 2 (03) :227-232

[5]

Bernard B, 1997, HEPATOLOGY, V25, P63, DOI 10.1053/jhep.1997.v25.pm0008985266

[6]

Boyer T D, 1997, Clin Liver Dis, V1, P31, DOI 10.1016/S1089-3261(05)70253-1

[7]

BOYER TD, 1982, HEPATOLOGY TXB LIVER, P464

[8]

BURROUGHS AK, 1990, SURG CLIN N AM, V70, P319

[9]

Chalasani N, 1999, AM J GASTROENTEROL, V94, P3285

[10] An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis [J].

Cho, JJ ;

Hocher, B ;

Herbst, H ;

Jia, JD ;

Ruehl, M ;

Hahn, EG ;

Riecken, EO ;

Schuppan, D .

GASTROENTEROLOGY, 2000, 118 (06) :1169-1178

← 1 2 3 4 5 →